PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
about
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosisCharacterization and expression of a novel alternatively spliced human angiopoietin-2Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen speciesPPAR(alpha) and PPAR(gamma) activators suppress the monocyte-macrophage apoB-48 receptorAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionUpregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophagesInflammation, stress, and diabetesSynthetic LXR ligand inhibits the development of atherosclerosis in miceTranscriptional regulation of the human carboxyl ester lipase gene in THP-1 monocytes: an E-box required for activation binds upstream stimulatory factors 1 and 2PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesisThe two variants of oxysterol binding protein-related protein-1 display different tissue expression patterns, have different intracellular localization, and are functionally distinctPeroxisome proliferator-activated receptor alpha mediates the adaptive response to fastingDisruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient miceTargeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in micePPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1PPARs and the cardiovascular systemAtherosclerosisAbsence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/IICD36: implications in cardiovascular diseaseCD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6).Decreased inducibility of TNF expression in lipid-loaded macrophagesRole of Peroxisome Proliferator-Activated Receptors in Inflammation ControlThe peroxisome proliferator activated receptor delta is required for the differentiation of THP-1 monocytic cells by phorbol esterDifferential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation.Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studiesIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Metabolic functions of FABPs--mechanisms and therapeutic implicationsEndothelial fatty acid transport: role of vascular endothelial growth factor BBreaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticlesPPAR-γ -- a possible drug target for complicated pregnanciesPerspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsPPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsIdentification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gammaOpportunities for the treatment of inflammation in cardiovascular diseaseLack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisActivation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesThe role of fatty acid binding proteins in metabolic syndrome and atherosclerosisGenomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) geneEndocrine disrupting chemicals and the developmental programming of adipogenesis and obesity
P2860
Q22004166-BF29AA74-A81E-48E4-BF74-D14EFA4ECAB4Q22253905-43434A90-C797-4A42-9EC6-54243EF640DFQ22253929-6EC8ACC3-0C07-485E-89D4-2D4934FE09A7Q24300059-7766F0D1-C4CA-41E9-A69C-08B27267957DQ24300694-0985AFDD-E275-4F7D-AF27-E2DD28733E2AQ24314013-7CB8F668-F991-454D-9B0A-28974FC8AA6AQ24523336-772ACF50-CEC6-4194-A59E-688FFF41520AQ24530617-B18E5D52-8D57-4823-8176-66C682DD5741Q24534236-94A4A528-3BCC-4F6C-A301-ECACBBFAED8AQ24553314-A93899E3-465C-472D-A38D-66780E76CAA7Q24554292-39EEC155-2277-4223-9923-C34EA7E6DE88Q24563197-FA56AE24-5B04-48CC-AF56-7DD30F51E0BEQ24563208-D9CF691C-584A-4555-A67B-235CCD2F4886Q24623151-6A181CDE-D16D-4FA8-A796-0882110040A6Q24633440-2B1B6555-D1EC-4D88-B626-AD4040AD7C8CQ24642728-C0E7C32F-D697-4226-816A-A5125665F601Q24644573-68C441C9-9FA9-4328-84D9-05631FA3C084Q24658096-3970E1F6-A080-413F-875C-72377EDA8920Q24678338-E697E92B-97E0-40FF-9E0D-8AEA17B59E7CQ24791158-0F36CBB7-DE1E-47E0-BB42-A6C1AB74E6EDQ24791561-07ECC8BA-48BE-4FD4-9CAA-BB4BD3CB50C6Q24796541-FC01575A-80AA-4D76-8E8D-8F1AF9E2C999Q24806798-C809F764-59F3-4EB9-A505-A2BA111BAB5AQ24815569-89FD9083-9284-4CF8-9EED-2CD92C9D9501Q25257578-22882773-459B-477C-A5DC-E40A8E81BD76Q26739984-002C88A0-41A6-41C1-A6C7-9076ABCDD0F5Q26799705-B90F07E9-DCF6-46B9-B19E-639389B4D32DQ26829121-AC537EE1-E666-4F00-B5A6-EFDD4EFBE0BFQ26830366-D3004F5A-728E-4B02-BF9D-E807E586E37BQ26863678-77D3EDF4-EB11-40E0-AEB6-7097E46F54F8Q26991440-9C73BC5E-06FA-4682-BEDC-C2D0D18B983AQ28066756-71AB977E-CDA9-4BBC-A6E7-D0D0260C762DQ28144779-E2BD1798-E3C0-4F4D-9006-4491CDFFE278Q28192292-52436268-96CE-48D3-8689-22751FF9B0E3Q28198287-48110FF8-D8DB-445E-94FF-6A4455CB3C88Q28214426-D1416676-D11E-485C-8461-89143880A323Q28221639-9B34DAB8-C562-4086-B0CC-E7D385B23F84Q28271189-69D034D5-6763-4B38-B752-98BE7275AA59Q28290435-102F7D38-4F2D-4E3D-BC08-C27BCE246BF6Q28307782-DE7B2348-7A5C-44FF-89B9-37A765181774
P2860
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@ast
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@en
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@en-gb
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@nl
type
label
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@ast
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@en
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@en-gb
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@nl
prefLabel
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@ast
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@en
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@en-gb
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@nl
P2093
P921
P3181
P1433
P1476
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
@en
P2093
P304
P3181
P356
10.1016/S0092-8674(00)81575-5
P407
P577
1998-04-01T00:00:00Z